Abstract
Background
The aims of this study were to identify Blastocystis subtypes (STs) in a cohort of Turkish patients with various gastrointestinal symptoms using a novel Real Time PCR method developed recently for Blastocystis detection and assess the relationship between Blastocystis STs and patient symptoms.
Methods
Totally, 617 stool samples of patients with gastrointestinal symptoms were examined with microscopy and inoculated in Jones medium. Blastocystis-positive samples were further assessed to identify coinfections with other possible pathogens, including bacteria and viruses. Diagnostic efficacies of microscopy, culture and Real-Time PCR were compared. PCR products were sequenced to identify the subtypes of Blastocystis isolates.
Results
Totally 94 (15.24%) samples were positive for Blastocystis after all methods. Among these, 83 of 94 (88.3%) samples were identified with all methods, while 11 were positive only with Real Time PCR. Diarrhea and abdominal pain were the leading symptoms in the patients. The only pathogenic agent identified in 76 of 94 (80.9%) patients was Blastocystis. Subtype 3 was the leading Blastocystis subtype (44.6%), while subtypes 6 and 7 were firstly isolated from symptomatic patients in our region.
Conclusion
Comparison of three diagnostic methods indicated Real Time PCR as the most sensitive and specific method. Blastocystis was the only pathogenic agent among symptomatic patients, with subtype 3 being predominant. Patients with subtypes 6 and 7 need further assessments concerning the zoonotic potential of Blastocystis.
Keywords: Blastocystis, Prevalence, Subtype, Pathogenicity, Turkey
Introduction
Blastocystis is the species name of common intestinal protists identified in the stools of humans and many animals worldwide. Although discovered more than 100 years ago, many biological properties of Blastocystis are still unresolved. They are probably the most common intestinal protozoa in parasitological surveys throughout the world, with prevalence rates ranging between 3% and 60% in different countries (1, 2).
There is a controversy about the pathogenicity of Blastocystis. Whether pathogenic or not, the parasite is remarkable in that it is capable of establishing chronic infections, for which there is no known eradication strategy (3). Patients infected with Blastocystis may remain asymptomatic, or suffer from gastrointestinal symptoms such as abdominal pain, diarrhea, nausea, vomiting, bloating and anorexia. To a lesser extent, patients may report dermatological complaints such as urticaria and intense itching (4-6). Many studies indicated the presence of Blastocystis only if five or more microorganisms were identified under x400 magnification (7). However, owing to the variation of the daily excretion of the microorganism, this measure may not be reliable to decide whether Blastocystis is pathogenic or not. Common use of molecular methods in Parasitology in the last decade improved the sensitivity and specificity of the laboratory diagnosis; in addition, molecular methods helped to clarify the transmission route, zoonotic potential and thus the significance of that parasitic infections in terms of public health. There is an extensive genetic diversity among the Blastocystis isolates and molecular analyses demonstrated 17 distinct Blastocystis subtypes, at least 9 of which have been found in humans with varying pathogenicity (3, 8-10). Clinical assessments on the relationship between Blastocystis subtypes and their pathogenicity have been on the rise in recent years (11-13).
Diagnosis of blastocystosis relies mainly on microscopy; however, variable shedding and polymorphic nature of Blastocystis may lower the sensitivity of direct examination of stool samples with saline-Lugol’s iodine solution as well as with concentration and trichrome staining methods (14). Short-term culture of stool samples is a practical and sensitive method to identify Blastocystis in stool samples (2). Recently, molecular methods have been used in the diagnosis, and the Real-Time PCR was found highly sensitive and specific for Blastocystis infection (15-17).
The aims of the present study were to determine the prevalence of Blastocystis infection as well as the subtypes of Blastocystis in a cohort of Turkish patients with gastrointestinal complaints from Manisa and Izmir provinces; compare the efficacies of diagnostic methods for blastocystosis, assess the relationship between the symptoms and Blastocystis subtypes, and assess whether there are subtype differences in the culture and stool isolates of the same patients, between April 2009 and December 2010.
Materials and Methods
Study Group
The study was conducted with the patients admitted to Ege University Medical School’s Hospital in Izmir and Ministry of Health’s Moris Sinasi International Pediatric Hospital in Manisa. All patients (n=617; 492 from Izmir and 125 from Manisa) reported gastrointestinal complaints; they were included in the study after they gave consent and answered the questions on the “Patient Information Form”, on their demographic features, risk factors and symptoms. The assessments of both prevalence and sociodemographic features of all patients (n=617) were determined initially. Efficacies of direct stool examination with saline and Lugol’s iodine solutions and culture were compared to Real Time PCR, retrospectively, for 314 randomly selected samples, 189 from Izmir and 125 from Manisa.
Parasitological Examination
All patient samples (n=617) were initially examined directly with saline and Lugol’s iodine solutions, formalin ethyl acetate concentration and cultivated within 30 minutes in Jones medium (18, 19). Samples considered positive by any method were examined for the presence of other intestinal parasites, including enzyme immunoassay (EIA) with RIDASCREEN®-C 1701 and RIDASCREEN®-C 1201 for Entamoeba sp. and Cryptosporidium sp., respectively. The remaining samples were preserved in -20°C for further assessments.
Microbiological Examination
Stool samples were initially examined microscopically for the presence of red and white blood cells. They were then inoculated in Eosin Methylene Blue (EMB) and Gram-Negative (GN) Broth media for Salmonella sp. and Shigella sp., and in Sorbitol Mac Conkey Agar medium for E. coli O157: H7 (20). The presence of Rotavirus and Adenovirus was assessed with EIA (RIDASCREEN® Rota Virus Enzyme Immune Assay, RIDASCREEN® Adeno Virus Enzyme Immune Assay).
Culture of Blastocystis
All stool samples were cultured using Jones medium (19). Two grams of fresh stool samples were added in culture tubes and kept in 37°C for 48 hours. Positivity of the culture samples was checked microscopically at 48 and 72 hours after cultivation. Positive culture samples were centrifuged at 1000 rpm for 5 minutes and 1.5-2.0 ml of the pellet were collected for DNA isolation and kept at -20°C. Culture method was chosen as the gold standard for diagnosis of Blastocystis infection (2).
Molecular Assessments
Limited financial resources of the study necessitated the application of molecular tests to only about 350 samples collected in the study. Therefore, apart from those 83 Blastocystis (+) samples identified initially with saline-Lugol and culture methods, we selected 273 more samples, reaching 356 samples for molecular assessment within the whole budget of the project. To prevent any bias in sample selection, the individuals were initially classified according to age, sex, profession and life-standard groups and certain number of samples were selected to represent each subgroup equally.
Real Time PCR procedure, derived from a recently-developed protocol (21), was applied to amplify a target sequence of 18S rRNA gene of Blastocystis using Light Cycler 480 (Roche® Applied Science, Germany) with the Taqman Assay, according to instructions of the manufacturer’s. The primers and the Taqman probe used for the assay were as follows: (21)
Blas-F CGTTGTTGCAGTTAAAAAGCTCGT
Blas-R GATTAATGAAAACATCCTTGGTAAATGC.
Blas-P CAgTTgggggTA+T+TCA+TA+T+TC
Taqman PCR conditions of amplification were 50°C for 2 minutes, 95°C for 10 minutes, 95°C for 15 seconds and 60°C for 1 minute. The last two steps were 45 cycles.
Sequencing of the Real Time PCR products of Blastocystis
Sequence analyses of positive stool and culture samples were conducted separately to assess any variation within the sequence results. The primers used for the sequencing of PCR-products were as follows:
Blasto_seq_F TTgTTgCAgTTAAAAAgCTCgTAgTTgA
Blasto_seq_R CgCACTTgTTCATCTTCCATAAATC
ABI PRISM® BigDye™ Terminator v3.0. (Applied Biosystems, USA) was used for sequencing of the products and the results were analysed on an ABI 3900 Sequencer (Applied Biosystems, USA). Total volume of the sequence reaction was 10 μl. For sequencing, 4 μl MQ, 3 μl Sequencing Buffer, 1μl primer (1,6 μM), 1 μl BigDye Terminator, 1 μl PCR-product (1:10 diluted) was used. The PCR-program used for sequencing was as follows (21);

Resulting sequences will be analysed and compared to previous Genbank entries using CodonCode Aligner® program (CodonCode Corporation, USA), and MEGA® (The Biodesign Institute, USA).
Statistical Analyses
The data were statistically assessed using SPSS® 13.0. Chi square test and percentages were used for data analysis, the P values below or equal to 0.05 were regarded as significant. Accuracy was calculated as sensitivity, specificity and positive and negative predictive values (PPV and NPV), with 95% confidence intervals (CI) calculated. Disease prevalence and positive and negative likelihood ratios (LR+ and LR-, respectively) were calculated, as well. All computations regarding accuracy were performed at Vassar Statswebsite (http://faculty.vassar.edu/lowry/clin1.html). The kappa coefficients were used to test the agreement between culture and direct stool examinations with saline and Lugol’s iodine solutions/PCR results.
Results
Patients enrolled in the study (n=617) were aged between 0 and 87 years (mean, 25.56 ± 25.4 years), and the ratio of male patients was slightly higher (51.4%). Among the age groups, Blastocystis-positive patients were predominantly between 20-29 years old (χ2: 13.68, P=0.03) (Table 1). Parasitological examination of the stool samples of these patients (n=617) with microscopy and culture revealed that 83 (13.5%) were positive for Blastocystis. Compared to microscopy, culture yielded significantly more Blastocystis-positive samples (microscopy: n=11; culture: n=80; χ2:10.44, P: 0.01). Vacuolar form was the most common morphological form of the parasite in microscopic examinations of direct smears and culture, as well.
Table 1.
Some demographic features of all (n=617) and Blastocystis-positive patients (n=94)*
| Demographic Feature | All Patients (n=617) (%) ** | Blastocystis-positive patients (n=94) (%) *** | P | |
|---|---|---|---|---|
| Sex | Female | 48.6 | 13.3 | P>0.05 |
| Male | 51.4 | 13.6 | ||
| Age Groups (yr) | 0-1 | 16.4 | 8.9 | P=0.030 |
| 2-9 | 26.4 | 11.0 | ||
| 10-19 | 14.4 | 16.9 | ||
| 20-29 | 7.3 | 28.9* | ||
| 30-39 | 5.5 | 17.6 | ||
| 40-49 | 7.9 | 14.3 | ||
| 50+ | 22.0 | 11.0 | ||
| Education | Non-literate | 30.0 | 9.7 | P=0.014 |
| Literate | 3.9 | 13.3 | ||
| Primary School graduate | 20.9 | 10.9 | ||
| Primary School student | 22.4 | 13.8 | ||
| Secondary School graduate | 3.4 | 33.3* | ||
| High School Graduate | 11.7 | 15.3 | ||
| University graduate | 7.8 | 25.0* | ||
| Drinking water resource | Well | 7.1 | 15.9 | P>0.05 |
| Bottled Water | 64.3 | 12.8 | ||
| Tap Water | 25.1 | 13.5 | ||
| Hand washing habit | Present | 86.2 | 13.7 | P>0.05 |
| Absent | 7.1 | 15.9 | ||
| Toilet type | Sewage system of the city | 90.6 | 12.5 | P=0.38 |
| Cesspool | 6.8 | 23.8* | ||
| Frequencyα of eating outside | High | 45.5 | 14.2 | P>0.05 |
| Low | 51.2 | 12.7 | ||
| Animal raising | Yes | 9.1 | 9.4 | P>0.05 |
| No | 87.3 | 12.7 | ||
| Poultry animal raising | Yes | 7.8 | 22.9* | P=0.04 |
| No | 92.2 | 12.7 | ||
Frequency of statistically significant Blastocystis infection/
% of column
% of line/
Eating ≥3 times a week outside home was considered “high”
Despite microscopic and molecular examinations were done with 617 and 356 stool samples, respectively, comparison of all methods used in the study were done with 314 stool samples due to the insufficiency of some of the stools submitted. This revealed 11 new positives, which were initially negative with microscopy and culture but turned out to be positive with Real Time PCR, making the final number of positives reach 94 (Table 1.). Sequence analyses that aim to identify the STs were conducted with 70 of 94 samples; the remaining 24 were not assessed due to low-quality DNA products or even negative PCR (Fig. 1; Table 1).
Fig. 1.

Real Time PCR curves of the patient samples and the controls
It was noted that sequence analyses of two of the 70 positive samples revealed different subtypes with stool and culture samples (Subtype 1 in culture while subtype 3 in stool in one sample, and subtype 2 in culture while subtype 3 in stool in the other sample).
Statistical analyses demonstrated that the agreement between the culture and PCR was excellent (K=0.86), while the agreement between the culture and O&P examination was weak (K=0.19). Compared to culture, the sensitivity of O&P examination was 12% (95% CI: 4% - 27%) and the specificity was 100% (95% CI: 98 % - 100%). O&P examination had a positive likelihood ratio of 0.87 (0.78- 0.98); however, the negative likelihood ratio calculation was not possible due to the values included one instances of zero. Real-Time PCR had a sensitivity of 100% (95% CI: 89%-100%), specificity of 95% (95% CI: 92%- 97 %), positive likelihood ratio of 24.72 (13.86-44.11), and negative likelihood ratio of zero.
Seventy-six of 94 patients (80.9%) were found to be infected only with Blastocystis, while 14 (14.8%) were coinfected with other parasites such as Giardia lamblia, Entamoeba histolytica/dispar, Cryptosporidium sp., Hymenolepis nana and Enterobius vermicularis, while 4 (4.8%) were coinfected with viruses such as Rotavirus and Adenovirus.
The correlation between the Blastocystis subtypes and some personal and environmental factors was assessed as well. Some demographic features of Blastocystis-positive individuals were shown in Table 1. An interesting outcome of the study was that Blastocystis infection was more common among university and secondary school graduates, compared to primary school graduates and no school graduates (χ2: 17.67, P=0.014). It was significantly more common as well, among the patients having cesspools instead of sewage system in their toilets (χ2: 4.31; P=0.38). Patients with daily habits such as less hand-washing especially before meals, more eating outside and using well water for drinking (instead of bottled water) at home, were found to be more susceptible to Blastocystis infection, without a significant difference, as well (Table 1).
One of the five patients in the study group reported close contact with various domestic animals; among them, Blastocystis infection was significantly more common among the owners of poultry animals (bird, chicken, quail) (χ2: 4.005, P=0.04). Subtype 3 was found to be the leading Blastocystis subtype among these patients, as expected. Subtype 7, which is unique to avians, was identified in one patient who owned domestic birds (Table 2).
Table 2.
Distribution of Blastocystis – positive patients according to Blastocystis subtypes and whether they were raising animals or not at the time of the survey (n=94)
| Blastocystis STs | Patients raising animals | Patients NOT raising animals | Total | |||
|---|---|---|---|---|---|---|
| Avian animals (Birds, poultry, etc.) | Cat | Dog | Farm Animals | |||
| ST1 | 1 | 0 | 1 | 1 | 10 | 13 (13.8) |
| ST2 | 1 | 0 | 0 | 0 | 10 | 11 (11.7) |
| ST3 | 5 | 2 | 1 | 0 | 34 | 42 (44.7) |
| ST6 | 0 | 0 | 0 | 0 | 1 | 1 (1.1) |
| ST7 | 1 | 0 | 0 | 0 | 0 | 1 (1.1) |
| Mixed ST2/ST3 | 0 | 0 | 0 | 0 | 2 | 2 (2.1) |
| Undefined | 3 | 1 | 1 | 1 | 18 | 24 (25.5) |
| Total | 11 | 3 | 3 | 2 | 75 | 94 (100.0) |
Patients reported many symptoms all of which belonged to gastrointestinal system. The leading symptoms in all as well as only Blastocystis-positive patients were found to be abdominal pain and diarrhea (Table 3).
Table 3.
Frequency of symptoms in all-study group and Blastocystis-positive group
| Symptoms | All-study group (n=617) (%) | Blastocytis-positive group (n=94) (%) |
|---|---|---|
| Abdominal pain | 58.0 | 60.6 |
| Diarrhea | 64.2 | 56.4 |
| Nausea / vomiting | 40.6 | 37.2 |
| Change in appetite | 23.1 | 26.6 |
| Fever | 21.3 | 12.8 |
| Itching | 8.2 | 6.4 |
There was no significant difference between the Blastocystis-positive group and all study groups for the frequency of gastrointestinal symptoms.
Discussion
The prevalence of Blastocystis infection is relatively higher in developing countries owing to poor hygiene, exposure to animals and consumption of contaminated water and food (2, 22). The prevalence rates of Blastocystis infection range between 1.05% and 15.0% among the symptomatic patients in different regions of Turkey (23). However, only the direct stool examination using saline and Lugol’s iodine solutions were used in some of these studies. In the present study, Blastocystis was found to be present in 94 of 356 (26.4%) stool samples with at least one method; this figure is between the reported data in developed and developing countries (3% - 60%), and relatively higher than the figures of previous studies in Turkey (1, 2, 23). It was also the leading parasite in our study group, which confirmed our initial hypothesis that Blastocystis was the most common intestinal parasite in patients with gastrointestinal symptoms.
This study is unique in that coinfections with Blastocystis were sought not only with routine parasitological methods, but also with molecular methods. This brought up an interesting finding of the study: the only infectious agent in the stool samples of 76 of 94 patients (80.8%) was Blastocystis. Regarding the current conflicting data about the pathogenicity of Blastocystis, we think that this is a significant finding to indicate the potential pathogenicity of this protozoon.
Reports suggest that Blastocystis infection should be considered as a prominent causative agent of gastrointestinal disturbances in children. The prevalence rates of Blastocystis infection among pre-school children were reported as 18.9% in Venezuela and 25% in Jordan; among the primary school children, they were 6.7% in Libya, 13.5% in Thailand, 16% in Venezuela and 22.4% in Colombia (22). In a previous study in Turkey, the prevalence of Blastocystis infection among the primary school children was 14.6% (24). In the present study, the prevalence of Blastocystis infection was 8.9% in 0-1 years, 11% in 2-9 years, and 16.9% in 10-19 years old groups; the differences were not statistically significant. However, the highest prevalence was found in the 20-29 years group, with a statistically significant difference.
Diagnosis of Blastocystis infection relies mainly on microscopic examination of stool samples; however, as there are many forms of the parasite, including the cysts which are often very small, the sensitivity of microscopic examination even with the stained smears may be rather low (2, 14). Cultivation is a good option to overcome this drawback, especially in laboratories with limited financial resources. Short-term culture (24-72 hours) of stool samples is reported to be more sensitive than microscopic examination, and suggested as the “gold standard” for the diagnosis of Blastocystis infection (2, 25). Thus, in the present study, culture was taken as the gold standard and found to be more sensitive significantly, compared to microscopic examination of stool samples for Blastocystis recovery. It is found almost as reliable as PCR to identify Blastocystis. Another advantage of culture method is the production of large amounts of parasites for further molecular genotyping studies, by which it is possible to get more precise data about the transmission route and origins of Blastocystis isolates that caused the infection (26, 27).
On the other hand, one drawback of the culture method is that in some instances it may allow the preferential growth of one subtype of a parasite over another if more than one subtype is present in the stool (28). In the present study, discordance in the subtypes of stool and culture samples was noted in 2 of 70 samples sequenced. This discordance is noteworthy, and warrants further assessments in future studies.
Application of molecular methods to Parasitology improved the sensitivity and specificity of diagnosis of Blastocystis infections (3, 22). Recently, several studies have described the use of conventional PCR for Blastocystis. Parkar and colleagues (28) demonstrated that culture followed by PCR was three times more sensitive than culture alone. In contrast, using conventional PCR alone, other studies demonstrated the ability to detect Blastocystis at concentrations as low as 13 and 32 parasites per 200 mg of stool (29). Today, real-time PCR is becoming more common for the diagnosis of parasitic infections. Sensitivity of Real Time PCR in the diagnosis of Blastocystis infection was found to be 95% in a trial in which real-time quantitative PCR was taken as the golden standard, while sensitivities of microscopy and culture were found as 29% and 52%, respectively (16). In the present study, assessments showed that the sensitivity and specificity of Real Time PCR was 100% and 95%, respectively, whereas 12% and 100% for O&P examination. These results confirm that microscopy on a single sample is not reliable for the diagnosis of Blastocystis infections. Real Time PCR is both sensitive and specific. On the other hand, PCR methods may detect DNA rather than living parasites.
Molecular analyses demonstrated that Blastocystis had extensive genetic diversity; analyses of small subunit of ribosomal RNA (SSU rRNA) identified 17 distinct Blastocystis subtypes, nine of which have been identified in humans but also in many animal species (8, 17, 25, 28, 30). The identification of Blastocystis subtypes contributed to the unveiling of the transmission routes and zoonotic potentials of this mysterious parasite. Subtype 3 seems to be the most common subtype in humans, followed by subtype 1 (22). Sequencing of 70 samples in our study group which comprised only of patients with gastrointestinal symptoms revealed that subtype 3 was again the most common Blastocystis subtype. The overall distribution of Blastocystis subtypes reflects those of Middle East, more than it shows the European countries (3, 8). As all patients in our study had gastrointestinal symptoms, all subtypes identified in our study (subtype 1, 2, 3, 6 and 7) may have varying degrees of pathogenicity. Recent data suggest that subtypes 1, 4 and 7 are pathogenic whereas subtypes 2, 3 and 6 were non-pathogenic (8, 22). However, recent reports state the possibility of intra-subtype variations in patients with and without symptoms, infected with Blastocystis subtypes known as pathogenic (11, 31). Thus, the detection of the subtypes 2, 3 and 6, which were reported as non-pathogenic in many previous studies, in symptomatic patients in our study may be due to intra-subtype variations, which warrants further assessments.
Epidemiologic studies revealed that some Blastocystis subtypes were identified in various animals and humans, whereas subtype 3 is probably anthropophylic only. Some animals are reservoirs of Blastocystis, which may constitute some human infections (2), and close contact with animals may be the source of some human infections. In the present study, raising cattle in a farm elevated the risk for Blastocystis infection, but the difference was not significant. Yet, close contact with the poultry animals (birds, chicken and quail) was found to be associated with higher risk, with a statistically significant difference.
Some recent surveys suggested that the incidence of Blastocytis infection was higher among the patients with gastrointestinal complaints, such as abdominal pain, diarrhea, flatulence and nausea, compared to non-symptomatic patients (22, 32, 33). In the present study, abdominal pain (59%) and diarrhea (55.4%) were the leading symptoms reported by the patients. Analyses of the symptoms revealed no statistically significant correlation between a symptom and the infection. It should be noted that 14.8% of the patients in our study group were coinfected with other parasitic agents, and 4.8% were coinfected with virus infections (Adenovirus and/or Rotavirus). Seventy-eight of 94 patients (82.9%) was infected only with Blastocystis, suggesting that Blastocystis may be the only causative agent of the symptoms in these patients. Blastocystis is a significant cause of diarrhea and other symptoms related to gastrointestinal tract, and thus it should be included in the evaluation of the patients (22, 32).
Conclusion
Blastocystis is a common parasitic infection, with varying levels of pathogenicity. The symptomatic profile of the patients infected only with Blastocystis in the present study is almost the same as the profile of the patients infected with other intestinal protozoa. More data should be reviewed to assess the pathogenicity of the subtypes. We believe that such studies will improve the clinicians’ awareness about the significance of Blastocystis and other parasitic infections in routine practice.
Acknowledgments
The current study is derived from the project (“The Frequency and Subtypes of Blastocystis in Patients with Gastrointestinal Symptoms”. Project No: 2009 Tıp12) funded by Ege University Department of Scientific Research. The authors declare that there is no conflict of interests.
References
- 1.Dagci H, Kurt O, Demirel M, Ostan I, Azizi NR, Mandiracioglu A, Yurdagul C, Tanyuksel M, Eroglu E, Ak M. The prevalence of intestinal parasites in the province of Izmir, Turkey. Parasitol Res. 2008;103:839–45. doi: 10.1007/s00436-008-1065-6. [DOI] [PubMed] [Google Scholar]
- 2.Tan KS. New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev. 2008;21:639–65. doi: 10.1128/CMR.00022-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Clark CG, van der Giezen M, Alfellani MA, Stensvold CR. Recent developments in Blastocystis research. Adv Parasitol. 2013;82:1–32. doi: 10.1016/B978-0-12-407706-5.00001-0. [DOI] [PubMed] [Google Scholar]
- 4.Tan KS, Singh M, Yap EH. Recent advances in Blastocystis hominis research: hot spots in terra incognita. Int J Parasitol. 2002;32:789–804. doi: 10.1016/s0020-7519(02)00005-x. [DOI] [PubMed] [Google Scholar]
- 5.Verma R, Delfanian K. Blastocystishominis associated acuteurticaria. Am J Med Sci. 2013;346(1):80–1. doi: 10.1097/MAJ.0b013e3182801478. [DOI] [PubMed] [Google Scholar]
- 6.Vogelberg C, Stensvold CR, Monecke S, Ditzen A, Stopsack K, Heinrich-Gräfe U, Pöhlmann C. Blastocystis sp. subtype 2 detection during recurrence of gastrointestinal and urticarial symptoms. Parasitol Int. 2010;59:469–71. doi: 10.1016/j.parint.2010.03.009. [DOI] [PubMed] [Google Scholar]
- 7.Stenzel DJ. Blastocystis hominis revisited. Clin Microbiol Rev. 1996;9:563–84. doi: 10.1128/cmr.9.4.563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Stensvold CR, Alfellani M, Clark CG. Levels of genetic diversity vary dramatically between Blastocystis subtypes. Infect Genet Evol. 2012;12:263–73. doi: 10.1016/j.meegid.2011.11.002. [DOI] [PubMed] [Google Scholar]
- 9.Nagel R, Cuttell L, Stensvold CR, Mills PC, Bielefeldt-Ohmann H, Traub RJ. Blastocystissubtypes in symptomatic and asymptomatic family members and pets and response to therapy. Intern Med J. 2012;42:1187–95. doi: 10.1111/j.1445-5994.2011.02626.x. [DOI] [PubMed] [Google Scholar]
- 10.Forsell J, Granlund M, Stensvold CR, Clark GC, Evengård B. Subtype analysis of Blastocystis isolates in Swedish patients. Eur J Clin Microbiol Infect Dis. 2012;31:1689–96. doi: 10.1007/s10096-011-1416-6. [DOI] [PubMed] [Google Scholar]
- 11.Kaneda Y, Horiki N, Cheng XJ, Fujita Y, Maruyama M, Tachibana H, Tachibana H. Ribodemes of Blastocystis hominis isolated in Japan. Am J Trop Med Hyg. 2001;65:393–6. doi: 10.4269/ajtmh.2001.65.393. [DOI] [PubMed] [Google Scholar]
- 12.Yoshikawa H, Wu Z, Kimata I, Iseki M, Ali IK, Hossain MB, Zaman V, Haque R, Takahashi Y. Polymerase chain reaction-based genotype classification among human Blastocystis hominis populations isolated from different countries. Parasitol Res. 2004;92:22–9. doi: 10.1007/s00436-003-0995-2. [DOI] [PubMed] [Google Scholar]
- 13.Jones MS, Ganac RD, Hiser G, Hudson NR, Le A, Whipps CM. Detection of Blastocystis from stool samples using real-time PCR. Parasitol Res. 2008;103:551–7. doi: 10.1007/s00436-008-1006-4. [DOI] [PubMed] [Google Scholar]
- 14.Stensvold R, Brillowska-Dabrowska A, Nielsen HV, Arendrup MC. Detection of Blastocystis hominis in unpreserved stool specimens by using polymerase chain reaction. J Parasitol. 2006;92:1081–7. doi: 10.1645/GE-840R.1. [DOI] [PubMed] [Google Scholar]
- 15.Jones MS, Whipps CM, Ganac RD, Hudson R, Boroom K. Association of Blastocystis subtype 3 and 1 with patients from an Oregon community presenting with chronic gastrointestinal illness. Parasitol Res. 2009;104:341–5. doi: 10.1007/s00436-008-1198-7. [DOI] [PubMed] [Google Scholar]
- 16.Poirier P, Wawrzyniak I, Albert A, Alaoui HE, Delbac F, Livrelli V. Development and evaluation of a real-time PCR assay for detection and quantification of Blastocystis parasites in human stool samples: prospective study of patients with hematological malignancies. J Clin Microbiol. 2011;49:975–83. doi: 10.1128/JCM.01392-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Stensvold CR, Ahmed UN, Andersen LO, Nielsen HV. Development and evaluation of a genus-specific, probe-based, internal-process-controlled real-time PCR assay for sensitive and specific detection ofBlastocystisspp. J Clin Microbiol. 2012;50:1847–51. doi: 10.1128/JCM.00007-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Garcia LS, Bruckner DA. Macroscopic and microscopic examination of fecal specimens. In: Garcia LS, Bruckner DA, editors. Diagnostic medical parasitology. Washington: American Society for Microbiology; 1993. pp. 501–35. [Google Scholar]
- 19.Leelayoova S, Taamasri P, Rangsin R, Naaglor T, Thathaisong U, Mungthin M. In vitro cultivation: a sensitive method for detecting Blastocystis hominis. Ann Trop Med Parasitol. 2002;96:803–7. doi: 10.1179/000349802125002275. [DOI] [PubMed] [Google Scholar]
- 20.Winn WC, Allen SD, Janda WM, Koneman E, Procop G, Schreckenberger P, Woods G. Koneman’s color atlas and textbook of diagnostic microbiology. 6. Philadelphia: Lippincott Williams and Wilkins; 2006. [Google Scholar]
- 21.Bart A, Wentink-Bonnema EM, Gilis H, Verhaar N, Wassenaar CJ, van Vugt M, Goorhuis A, van Gool T. Diagnosis and subtype analysis of Blastocystis sp. in 442 patients in a hospital setting in the Netherlands. BMC Infect Dis. 2013;13:389. doi: 10.1186/1471-2334-13-389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.TanK S, Mirza H, Teo JD, Wu B, Macary PA. Current views on the clinical relevance of Blastocystis spp. Curr Infect Dis Rep. 2010;12:28–35. doi: 10.1007/s11908-009-0073-8. [DOI] [PubMed] [Google Scholar]
- 23.Ozcakir O, Güreser S, Ergüven S, Yılmaz YA, Topaloğlu R, Hascelik G. Characteristics of Blastocystis hominis. Acta Parasitologica Turcica. 2007;31:277–82. [PubMed] [Google Scholar]
- 24.Aksoy U, Akisu C, Bayram Delibas S, Ozkoc S, Sahin S, Usluca S. Demographic status and prevalence of intestinal parasitic infections in schoolchildren in Izmir, Turkey. Turk J Pediatr. 2007;49:278–82. [PubMed] [Google Scholar]
- 25.Stensvold CR, Arendrup MC, Jespersgaard C, Molbak K, Nielsen HV. Detecting Blastocystis using parasitologic and DNA-based methods: a comparative study. Diagn Microbiol Infect Dis. 2007;59:303–7. doi: 10.1016/j.diagmicrobio.2007.06.003. [DOI] [PubMed] [Google Scholar]
- 26.Termmathurapoj S, Leelayoova S, Aimpun P, Thathaisong U, Nimmanon T, Taamasri P, Mungthin M. The usefulness of short-term in vitro cultivation for the detection and molecular study of Blastocystis hominis in stool specimens. Parasitol Res. 2004;93:445–7. doi: 10.1007/s00436-004-1157-x. [DOI] [PubMed] [Google Scholar]
- 27.Thathaisong U, Worapong J, Mungthin M, Tan-Ariya P, Viputtigul K, Sudatis A, Noonai A, Leelayoova S. Blastocystis isolates from a pig and a horse are closely related to Blastocystis hominis. J Clin Microbiol. 2003;41:967–75. doi: 10.1128/JCM.41.3.967-975.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Parkar U, Traub RJ, Kumar S, Mungthin M, Vitali S, Leelayoova S, Morris K, Thompson RC. Direct characterization of Blastocystis from faeces by PCR and evidence of zoonotic potential. Parasitology. 2007;134:359–67. doi: 10.1017/S0031182006001582. [DOI] [PubMed] [Google Scholar]
- 29.Pasqui AL, Savini E, Saletti M, Guzzo C, Puccetti L, Auteri A. Chronic urticaria and Blastocystis hominis infection: a case report. Eur Rev Med Pharmacol Sci. 2004;8:117–20. [PubMed] [Google Scholar]
- 30.Noël C, Dufernez F, Gerbod D, Edgcomb VP, Delgado-Viscogliosi P, Lip-Chuen Ho, Singh M, Wintjens R, Sogin ML, Capron M, Pierce R, Zenner L, Viscogliosi E. Molecular phylogenies of Blastocystis isolates from different hosts: implications for genetic diversity, identification of species, and zoonosis. J Clin Microbiol. 2005;43:348–55. doi: 10.1128/JCM.43.1.348-355.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Hussein EM, Hussein AM, Eida MM, Atwa MM. Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats. Parasitol Res. 2008;102:853–60. doi: 10.1007/s00436-007-0833-z. [DOI] [PubMed] [Google Scholar]
- 32.Stensvold CR, Lewis HC, Hammerum AM, Porsbo LJ, Nielsen SS, Olsen KEP, Arendrup MC, Nielsen HV, Molbak K. Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite. Epidemiol Infect. 2009;137:1655–63. doi: 10.1017/S0950268809002672. [DOI] [PubMed] [Google Scholar]
- 33.Kaya S, Cetin ES, Aridogan BC, Arikan S, Demirci M. Pathogenicity of Blastocystis hominis, a clinical reevaluation. Acta Parasitologica Turcica. 2007;31:184–7. [PubMed] [Google Scholar]
